There are currently 1376 clinical trials in Atlanta, Georgia looking for participants to engage in research studies. Trials are conducted at various facilities, including Emory University, Emory University Hospital, Children's Healthcare of Atlanta and Emory University Hospital/Winship Cancer Institute. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia
NCT04447989
Recruiting
This is a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study of sildenafil in premature infants (inpatient in Neonatal Intensive Care Units (NICUs)) with severe bronchopulmonary dysplasia (BPD).
Gender:
All
Ages:
29 weeks and below
Trial Updated:
06/02/2023
Locations: Emory Children's Center, Atlanta, Georgia
Conditions: Bronchopulmonary Dysplasia of Newborn
Register for Updates
Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis
NCT05743946
Recruiting
Study participants with non-cystic fibrosis bronchiectasis will be given Trikafta for four weeks. The researchers will monitor clinical endpoints, quality of life, and weight. Additionally, cutaneous punch biopsy material will be collected from each participant to test cellular response to Trikafta.
Gender:
All
Ages:
18 years and above
Trial Updated:
06/02/2023
Locations: The Emory Clinic, Atlanta, Georgia
Conditions: Non-cystic Fibrosis Bronchiectasis
Register for Updates
DECIDE: Dyads and Families
NCT05139290
Recruiting
The purpose of this study is to design and test a decision-making program that is tailored to support adult daughters making healthcare decisions for their parents who are living with memory loss to improve the quality of life of African American families. There are two phases of this research study. The first phase will collect information by surveys and/or interviews. The surveys and interviews will ask questions about demographics (e.g., age, race/ethnicity), culture, health, family dynamics... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/02/2023
Locations: Emory Healthcare Integrated Memory Care Clinic, Atlanta, Georgia +2 locations
Conditions: Dementia, Alzheimer Disease, Caregiver Burden
Register for Updates
Immunologic Responses to a Live Attenuated Oral Cholera Vaccine
NCT03251495
Recruiting
The primary objective of this study is to evaluate the antibody response to the cholera vaccine, Vaxchora®, in healthy subjects. Investigators also seek to evaluate additional markers of the adaptive immune response including plasmablasts, activated B cells, memory B cells, and T cell responses in healthy subjects receiving cholera vaccine, produce monoclonal antibodies against cholera, and evaluate the safety and reactogenicity in healthy subjects receiving cholera vaccine.
Gender:
All
Ages:
Between 18 years and 49 years
Trial Updated:
06/01/2023
Locations: The Hope Clinic of Emory University, Atlanta, Georgia
Conditions: Cholera
Register for Updates
Treadmill Training in People With Parkinson's Disease
NCT05239026
Recruiting
The study will explore if coupling speed and cadence during treadmill training elicit more benefits than controlling speed alone in individuals with Parkinson's disease.
Gender:
All
Ages:
Between 18 years and 89 years
Trial Updated:
05/31/2023
Locations: Georgia State University, Atlanta, Georgia
Conditions: Parkinson Disease
Register for Updates
Clarithromycin Mechanisms in Hypersomnia Syndromes
NCT04026958
Recruiting
The purpose of this study is to evaluate a medication called clarithromycin for treating sleepiness in narcolepsy and idiopathic hypersomnia. Studies have shown that clarithromycin can reduce sleepiness, but researchers do not know how clarithromycin does this. This study will look at brain activity (on magnetic resonance imaging [MRI]), inflammation, bacteria living in the gut, and cerebrospinal fluid, to better understand how clarithromycin can reduce sleepiness. This study will recruit 92 par... Read More
Gender:
All
Ages:
Between 18 years and 60 years
Trial Updated:
05/31/2023
Locations: Emory Sleep Center, Atlanta, Georgia
Conditions: Narcolepsy Without Cataplexy, Idiopathic Hypersomnia, Narcolepsy With Cataplexy
Register for Updates
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
NCT01060371
Recruiting
Spinocerebellar ataxias (SCA) are genetic neurological diseases that cause imbalance, poor coordination, and speech difficulties. There are different kinds of SCA and this study will focus on types 1, 2,3, and 6 (SCA 1, SCA 2, SCA 3 , also known as Machado-Joseph disease and SCA 6). The diseases are rare, slowly progressive, cause increasingly severe neurological difficulties and are variable across and within genotypes. The purpose of this research study is to bring together a group of experts... Read More
Gender:
All
Ages:
6 years and above
Trial Updated:
05/30/2023
Locations: Emory University, Atlanta, Georgia
Conditions: Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3, Spinocerebellar Ataxia Type 6
Register for Updates
Evaluating Effectiveness of Powered Drill Bone Marrow Biopsy
NCT03078452
Recruiting
Since the introduction of the Jamshidi needle in 1971, new advances in bone marrow sampling have not been seen. In 2007, a new battery-powered bone marrow biopsy system was developed. This technology, using a battery-powered drill to operate the needle accessing the posterior iliac bone, was approved by the Food and Drug Administration (FDA) and is currently commercially available. Few randomized controlled trials (RCTs) have compared the use of the battery-powered bone marrow biopsy system to... Read More
Gender:
All
Ages:
All
Trial Updated:
05/30/2023
Locations: Emory University/Winship Cancer Institute, Atlanta, Georgia
Conditions: Plasma Cell Myeloma
Register for Updates
Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
NCT00243776
Recruiting
The study team will use small pieces of human hearts which are removed as part of a required surgical procedure to study different objectives. One of the objective is how calcium ions pass through the membrane of heart cells in order to tell the heart cell how much force to contract with when the heart beats. Investigators will also study the proteins and RNA of these pieces to determine how the newborn heart cells control their force of contraction differently from adult heart cells. Investigat... Read More
Gender:
All
Ages:
20 years and below
Trial Updated:
05/26/2023
Locations: Emory University School of Medicine, Atlanta, Georgia
Conditions: Congenital Heart Disease, Tetralogy of Fallot
Register for Updates
International CIPN Assessment and Validation Study
NCT04633655
Recruiting
This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an international multi-center study.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/24/2023
Locations: Northside Hospital, Atlanta, Georgia
Conditions: Chemotherapy-induced Peripheral Neuropathy, Quality of Life
Register for Updates
ProACT Post-Approval Study
NCT03767595
Recruiting
The ProACT Post Approval Study is a 5-year prospective, open-label, multi-center study designed to evaluate the long-term incidence of urethral stricture and device erosion after ProACT implantation. In addition, the study will evaluate whether treatment with ProACT affects clinical outcomes after subsequent SUI therapies.
Gender:
Male
Ages:
50 years and above
Trial Updated:
05/19/2023
Locations: Emory University, Atlanta, Georgia
Conditions: Stress Urinary Incontinence
Register for Updates
Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis
NCT04754945
Recruiting
This phase I trial studies the side effects of isatuximab and to see how well it works in treating patients with high risk immunoglobulin light chain amyloidosis (AL amyloidosis). Isatuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/17/2023
Locations: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia +1 locations
Conditions: AL Amyloidosis
Register for Updates